低分子量肝素在癌症患者静脉血栓栓塞症二级预防中比华法林更安全吗？ - Suppr

Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?

Caine Graham J, Lip Gregory Y H

Arch Intern Med. 2003 May 26;163(10):1243-4; author reply 1244. doi: 10.1001/archinte.163.10.1243-b.

Abstract

摘要

Arch Intern Med. 2003 May 26;163(10):1243-4; author reply 1244. doi: 10.1001/archinte.163.10.1243-b.

Arch Intern Med. 2003 May 26;163(10):1242-3; author reply 1244. doi: 10.1001/archinte.163.10.1242-c.

Arch Intern Med. 2003 May 26;163(10):1243; author reply 1244. doi: 10.1001/archinte.163.10.1243-a.

Arch Intern Med. 2002;162(15):1729-35. doi: 10.1001/archinte.162.15.1729.

J Oncol Pharm Pract. 2007 Jun;13(2):85-97. doi: 10.1177/1078155207079169.

Thromb Haemost. 2009 Apr;101(4):762-9.

J Clin Oncol. 2005 Oct 1;23(28):7248-50; author reply 7250. doi: 10.1200/JCO.2005.01.7897.

Semin Thromb Hemost. 2003 Dec;29 Suppl 1:9-11. doi: 10.1055/s-2003-45410.

Clin Evid. 2002 Jun(7):199-213.

MMW Fortschr Med. 2003 May 8;145(19):suppl 3-4.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。